Current Edition

News

Positive Phase III results for plant-based COVID-19 vaccine

Medicago and GlaxoSmithKline (GSK) have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate …

Continue Reading →
News

Next virus could be more lethal than COVID-19, warns Oxford vaccine creator

With the emergence of the new Omicron variant bringing into question the effectiveness of current vaccines, scientists caution that viruses will continue to evolve. According …

Continue Reading →
News

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A …

Continue Reading →
Current Features

Hyper-collaboration in Healthcare and Life Sciences – The New Paradigm

The COVID-19 pandemic demonstrated the ability of the healthcare and life science industry to respond to unexpected needs with unprecedented speed. However, independent of the …

Continue Reading →
News

UK recognises Covaxin as valid COVID-19 vaccine for travel

Travellers vaccinated with Bharat Biotech’s Covaxin will now be able to enter the UK, as the vaccine has been added to the approved list. This …

Continue Reading →
News

Pfizer and BioNTech announce Phase 3 trial data showing high efficacy of a booster dose of their COVID-19 vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of …

Continue Reading →
News

CHMP positive option for Pfizer-BioNTech COVID-19 vaccine in the EU

Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the administration of the …

Continue Reading →
Volume 13 Issue 3

Minimising Vaccine Wastage with Advanced Refrigerator and Freezer Technologies

Despite intense global efforts to ramp up COVID-19 vaccine production and distribution, many of these doses are still not reaching people’s arms, with hundreds of …

Continue Reading →
News

SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of Phase 3 clinical study of SK’s COVID-19 vaccine candidate, GBP510, in combination with …

Continue Reading →